In 2023, Geoffrey S. Martha earned $3.56M in total compensation at Medtronic, including $1.35M salary and $1.91M bonus. Most recently acquired 40,000 shares in Jul 2024. Currently holds stock worth $27.64M. 5+ years at the helm of Medtronic.
Compensation History
Annual executive compensation data for Geoffrey S. Martha, including salary, bonuses, and stock awards.
Year
2023
Total Compensation
$3.56M
Salary
$1.35M
Bonus
$1.91M
Other
$305.50K
Salary
$1.35MBoard Justification
The compensation philosophy is designed to align executive compensation with company performance, emphasizing market competitiveness and pay-for-performance principles.
Bonus
$1.91MBoard Justification
The bonus is based on the Medtronic Incentive Plan (MIP) which includes performance metrics such as revenue growth, diluted EPS, and free cash flow, with individual performance modifiers.
Other Compensation
$305.50KBoard Justification
This includes a business allowance of $40,000 and other personal benefits totaling $223,146.
Restricted Stock
Board Justification
No stock was vested in 2023 as the focus is on the performance share units and stock options that are not included in the total compensation calculations.
Performance Metrics
The performance metrics for the CEO's compensation in 2023 included revenue growth, non-GAAP diluted EPS, and free cash flow.
Geoffrey S. Martha
CEO of Medtronic
Education
N/A
Field of Expertise
Business & Management - Business Development
Sector of Economy
Healthcare
Born
January 1, 1970 - 55 years ago
CEO of Medtronic for
5 years 7 months (Apr 2020 - Present)
Previous Experience
Senior Vice President of Strategy and Business Development at Medtronic
Other Medtronic CEOs
Holdings
Track Geoffrey S. Martha's stock holdings and portfolio value over time.
Total Stock Sold
$12.31M
$12.31M
118,471 MDT shares
What if they kept their stock?
If Geoffrey S. Martha didn't sell their stock, today they would have:
Extra MDT118,471 shares worth $12.01M.
This is -2.48% and $305.60K less than what they got when they sold the stock.
Insider Trading
Geoffrey S. Martha's recent stock transactions, purchases, and sales filed with the SEC.
40,000 shares
MDT
Jul 29, 2024
Received
$1.60M
MDT at $83.79/share
Jun 7, 2024
Sale
18,165 shares
MDT
Aug 3, 2023
Received
34,185 shares
MDT
Jul 31, 2023
Received
28,471 shares
MDT
Aug 1, 2022
Received
$1.54M
MDT at $132.67/share
Aug 25, 2021
Sale
19,047 shares
MDT
Aug 2, 2021
Received
$1.44M
MDT at $125.29/share
Jun 28, 2021
Sale
$1.39M
MDT at $118.83/share
Apr 5, 2021
Sale
23,118 shares
MDT
Aug 3, 2020
Received
Rivals
Compare Geoffrey S. Martha with competitor CEOs and industry peers.
Kevin Sayer
CEO of DexCom
2023 Compensation
Stock
$13.51M
Salary
$1.09M
Bonus
$1.99M
Other
$143.54K
Total Holdings
$26.32M
Joaquin Duato
CEO of Johnson & Johnson
2024 Compensation
Stock
$7.13M
Salary
$1.60M
Bonus
$3.22M
Other
$1.08M
Total Holdings
$1.09M
Kevin A. Lobo
CEO of Stryker
2024 Compensation
Stock
$13.66M
Salary
$1.44M
Bonus
$2.94M
Other
$897.87K
Total Holdings
$106.99M
Robert B. Ford
CEO of Abbott
2024 Compensation
Stock
$8.57M
Salary
$1.50M
Bonus
$2.86M
Other
$619.00K
Total Holdings
$23.06M
Marc N. Casper
CEO of Thermo Fisher Scientific
2024 Compensation
Stock
$0.00
Salary
$1.74M
Bonus
$5.51M
Other
$537.49K
Total Holdings
$1.17B
Gary S. Guthart
CEO of Intuitive Surgical
2022 Compensation
Stock
$5.79M
Salary
$873.08K
Bonus
$1.36M
Other
$1.50K
Total Holdings
$11.23M